These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29407134)

  • 1. Effectiveness of new generation drug-eluting stents in ostial right coronary artery lesions.
    De Rosa M; Santulli G
    Int J Cardiol; 2018 Mar; 254():84-86. PubMed ID: 29407134
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
    Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
    Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and long-term outcomes of drug-eluting stent implantations in aorto-ostial, left anterior descending artery-ostial, and nonostial lesions.
    Hsieh IC; Chen CC; Chang SH; Hsieh MJ; Wang CY; Lee CH; Lin FC
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):727-34. PubMed ID: 23592601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating bifurcations with drug-eluting balloon: an indication not ready for prime time.
    Belardi JA; Albertal M
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1147-8. PubMed ID: 23225652
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis.
    Kim YH; Lee JH; Roh JH; Ahn JM; Yoon SH; Park DW; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Seung KB; Shin WY; Lee NH; Lee BK; Lee SG; Nam CW; Yoon J; Yang JY; Hyon MS; Lee K; Jang JS; Kim HS; Park SW; Park SJ
    JACC Cardiovasc Interv; 2015 Apr; 8(4):550-60. PubMed ID: 25907082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year outcome of the use of paclitaxel-eluting stents in aorto-ostial lesions.
    Tsuchida K; Daemen J; Tanimoto S; García-García HM; Kukreja N; Vaina S; Ong AT; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW
    Int J Cardiol; 2008 Oct; 129(3):348-53. PubMed ID: 18031845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term outcomes of ostial stentings among bare-metal stents, sirolimus-eluting stents, and paclitaxel-eluting stents.
    Hsieh IC; Hsieh MJ; Chang SH; Wang CY; Lee CH; Lin FC; Chen CC
    Coron Artery Dis; 2013 May; 24(3):224-30. PubMed ID: 23571311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present status of coronary bifurcation stenting.
    Sukhija R; Mehta JL; Sachdeva R
    Clin Cardiol; 2008 Feb; 31(2):63-6. PubMed ID: 17763364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy comparison between drug-eluting stents versus cutting balloon angioplasty followed by bare metal stents for the treatment of ostial lesions of the left anterior descending coronary artery].
    Chen JL; Gao LJ; Gao RL; Yang YJ; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug; 36(8):702-5. PubMed ID: 19100110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus.
    Ali RM; Degenhardt R; Zambahari R; Tresukosol D; Ahmad WA; Kamar Hb; Kui-Hian S; Ong TK; bin Ismail O; bin Elis S; Udychalerm W; Ackermann H; Boxberger M; Unverdorben M
    EuroIntervention; 2011 May; 7 Suppl K():K83-92. PubMed ID: 22027736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Coated Balloons in Small Vessels: Preferred Strategy to Drug-Eluting Stents?
    Abbott JD; Wykrzykowska JJ; Lenselink C
    JACC Cardiovasc Interv; 2023 May; 16(9):1062-1064. PubMed ID: 37164604
    [No Abstract]   [Full Text] [Related]  

  • 16. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.
    Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions.
    Al-Lamee R; Ielasi A; Latib A; Godino C; Mussardo M; Arioli F; Figin F; Piraino D; Carlino M; Montorfano M; Chieffo A; Colombo A
    Am J Cardiol; 2011 Oct; 108(8):1055-60. PubMed ID: 21791332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Percutaneus coronary interventions for ostial lesions].
    Wöhrle J; Markovic S
    Herz; 2016 Nov; 41(7):579-584. PubMed ID: 27480783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary ostial stenosis after aortic valve replacement: successful treatment of 2 patients with drug-eluting stents.
    Ziakas AG; Economou FI; Charokopos NA; Pitsis AA; Parharidou DG; Papadopoulos TI; Parharidis GE
    Tex Heart Inst J; 2010; 37(4):465-8. PubMed ID: 20844624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to "Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection" by Conrotto F et al.
    Ye Z; Su Q; Li L
    Int J Cardiol; 2017 Nov; 247():32. PubMed ID: 28916072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.